Table 2.

Age-adjusted testicular cancer incidence rates per 100,000 person-years for the full cohort and different racial groups, stratified by age and subtype

	Total	NHW	HW	Black	API
All ages	2.60(2.48–2.70)	3.05(2.87–3.19)	2.28(2.11–2.40)	0.58(0.54–0.68)	1.22(1.13–1.32)
0–39	3.09(3.04–3.14)	3.67(4.30–4.45)	2.82(2.72–2.90)	0.62(0.54–0.70)	1.49(1.28–1.56)
40–64	2.54(2.48–2.60)	2.94(2.59–3.45)	1.59(1.47–1.68)	0.68(0.58–0.78)	1.10(0.95–1.19)
65+	0.50(0.48–0.53)	0.54(0.52–0.59)	0.33(0.21–0.44)	0.17(0.11–0.24)	0.30(0.17–0.39)
Subtype
Seminomas	1.55(1.52–1.57)	2.08(2.04–2.12)	1.19(1.14–1.25)	0.36(0.33–0.40)	0.60(0.56–0.65)
Teratomas	0.72(0.70–0.73)	0.94(0.91–0.96)	0.72(0.68–0.75)	0.14(0.12–0.16)	0.26(0.23–0.29)
ECs	0.27(0.26–0.28)	0.38(0.37–0.40)	0.22(0.20–0.24)	0.04(0.03–0.06)	0.10 (0.08–0.12)
Non-Seminomas	0.08(0.07–0.09)	0.10(0.09–0.10)	0.09(0.08–0.10)	0.03(0.02–0.04)	0.03(0.02–0.05)

Diagnoses occurred in the period from 1973 to 2015 using data from the SEER 9 database. Data are estimated rates (95% confidence intervals), age-adjusted using the U.S. 2000 Census population.

NHW non-Hispanic whites, HW Hispanic whites, API Asians and Pacific Islanders, ECs embryonal carcinomas